tel: (646)-791-2397 info@synergycap1.com
  • Facebook
  • Twitter
  • Facebook
  • Twitter
Synergy Capital
  • Business Financing
  • Careers
  • Partner
  • Apply
  • About Us
  • Contact Us
  • Synergy Capital
  • News
Select Page

Wabash to buy Supreme Industries

by synergycap1 | Aug 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Non-Bank Loans, Working Capital

LAFAYETTE, Ind. – Wabash National has agreed to buy truck body builder Supreme Industries. The deal is worth US$21 per share, equal to US$364 million. Supreme is the second largest manufacturer of truck bodies in the U.S., with 2016 sales of $299 million. It has...

‘Not helpful,’ Donald: World leaders react to Trump’s ‘fire and fury’ comments

by synergycap1 | Aug 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

Many world leaders have yet to weigh in on Trump’s comments; those that have appear to view the president’s rhetoric as more likely to escalate the situation than to settle it.

Super Charge Your Business With a Chatbot

by synergycap1 | Aug 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Finance, Innovate, Working Capital

chatbot, conversational UI, Marketing, call center, B2B, B2C, digital, UX, design, customer

Planners OK TOD project next to Dunwoody, Ga., MARTA station

by synergycap1 | Aug 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Working Capital

A 16-story office tower and a 10-story hotel next to the Dunwoody MARTA station will advance to the City Council with certain conditions. The Dunwoody Planning Commission voted 3-1 Tuesday for the transit-oriented plan by Trammell Crow Co. at 1134 Hammond Drive,...

Jonathan Silverstein on funding the fight against Parkinson’s

by synergycap1 | Aug 9, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital

Jonathan Silverstein, OrbiMed and Silverstein Foundation, discusses how his foundation is working to develop drugs to cure Parkinson’s disease.
« Older Entries
Next Entries »
Copyright © 2016 Synergy Capital. All rights reserved.